Translating the findings to the murine model, we found that CD8+ T cells express CCR5 preferentially at the lesions and that deletion of CCR5 in CD8+ T cells dampens severe pathology in a model of cutaneous leishmaniasis. This evidence concerns the gene CCR5 and cutaneous leishmaniasis.